Naoto Nishii
Overview
Explore the profile of Naoto Nishii including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
113
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Su Y, Ouchi R, Daroonpan P, Hamagaki M, Ikeda T, Rika N, et al.
Cancer Immunol Immunother
. 2025 Mar;
74(4):130.
PMID: 40025278
Objectives: An understanding of the tumor immune microenvironment is required to improve treatment, especially the selection of immune checkpoint inhibitors (ICIs). In this study, we stratified the immunotypes of tongue...
2.
Hirai H, Kinoshita N, Nishii N, Oikawa Y, Kugimoto T, Kuroshima T, et al.
Surg Oncol
. 2024 Oct;
57:102146.
PMID: 39357094
Objective: To analyze the clinical characteristics of patients with oral squamous cell carcinoma aged ≥80 years, focusing on surgical treatments. Study Design: We reviewed patients with oral squamous cell carcinoma...
3.
Tomioka H, Nishii N, Oikawa Y, Kugimoto T, Kuroshima T, Hirai H, et al.
Heliyon
. 2024 Feb;
10(1):e23120.
PMID: 38332864
Objective: The accurate assessment of the involvement of mandibular gingival squamous cell carcinoma (SCC) is essential for determining the extent of resection and is also useful for predicting lymph node...
4.
Kugimoto T, Nishii N, Oikawa Y, Kuroshima T, Hirai H, Tomioka H, et al.
Front Oncol
. 2023 Oct;
13:1168376.
PMID: 37901328
Background: This study aimed to determine the patterns of invasion of oral squamous cell carcinoma (OSCC) into the bucco-mandibular space (BMS) using detailed histopathological analysis and to assess clinical outcomes....
5.
Daroonpan P, Ouchi R, Zhang C, Nagai S, Nishii N, Kashima Y, et al.
Oral Oncol
. 2023 Jun;
143:106458.
PMID: 37329869
Objectives: Understanding the tumor immune microenvironment is becoming increasingly necessary for risk prediction and treatment selection. In particular, oral cancer has various immunosuppressive characteristics in the tumor microenvironment. Therefore, we...
6.
Hirai H, Nishii N, Oikawa Y, Ohsako T, Kugimoto T, Kuroshima T, et al.
Oncol Lett
. 2023 May;
25(6):226.
PMID: 37153031
The present study aimed to determine the risk factors associated with cervical lymph node metastasis (CLNM) in patients with buccal mucosa squamous cell carcinoma (BMSCC). This retrospective study included patients...
7.
Kugimoto T, Yamagata Y, Ohsako T, Hirai H, Nishii N, Kayamori K, et al.
World J Clin Cases
. 2022 Dec;
10(34):12742-12749.
PMID: 36579093
Background: Oral liposarcoma is an extremely rare lesion that is often clinically misdiagnosed as a benign tumor due to its asymptomatic and indolent clinical course. Here, we report a case...
8.
Widyagarini A, Nishii N, Kawano Y, Zhang C, Azuma M
Biochem Biophys Res Commun
. 2022 May;
614:100-106.
PMID: 35576680
T-cell responses are fine-tuned by positive and negative co-signal molecules expressed on immune cells and adjacent tissues. VSIG4 is a newly identified member of the B7 family of ligands, which...
9.
Noji R, Kano Y, Hirai H, Onishi I, Nishii N, Yoshimura R, et al.
Oral Oncol
. 2021 Dec;
124:105666.
PMID: 34896892
Patients with recurrent or metastatic squamous cell carcinoma of the head and neck (R/M HNSCC) have a poor prognosis. Recently, the use of immune checkpoint inhibitors (ICIs) for drug treatment...
10.
Nishii N, Hirotsu Y, Koida N, Takahashi Y, Takagawa Y, Amemiya K, et al.
Anticancer Res
. 2021 Jan;
41(2):1035-1040.
PMID: 33517312
Background/aim: The definition of multiple oral cancers is based on the distances between the tumors. However, it is not possible to accurately predict tumor origins based only on clinical criteria....